Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes
Open Access
- 20 January 2011
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 34 (2) , 510-517
Abstract
OBJECTIVE Insulin analogs are increasingly used in patients with type 2 diabetes. We compared the effect of basal, biphasic, prandial, and basal-bolus insulin regimens with insulin analogs to reach the hemoglobin A1c (HbA1c) target of 1c target of 30. RESULTS We found 16 RCTs, with 20 comparisons and 7,759 patients. A greater proportion of patients achieved the HbA1c goal of 1c goal (odds ratio 1.75 [95% CI 1.11–2.77]), with no greater hypoglycemia or weight gain. The effect of insulin analogs on long-term diabetes complications is still lacking. CONCLUSIONS A greater proportion of type 2 diabetic patients can achieve the HbA1c goal 1c goal.Keywords
This publication has 36 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Three-Year Efficacy of Complex Insulin Regimens in Type 2 DiabetesNew England Journal of Medicine, 2009
- DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week ResultsDiabetes Care, 2009
- Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trialDiabetes Care, 2009
- Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisCanadian Medical Association Journal, 2009
- Heart Disease and Stroke Statistics—2009 UpdateCirculation, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient educationPatient Education and Counseling, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986